Meropenem 125 mg Injection IP – MORPEX 125

Meropenem 125 mg Injection IP – Broad-Spectrum Defense against Infections

MORPEX 125 – Meropenem 125 mg Injection IP, a broad-spectrum carbapenem antibiotic helps to manage severe bacterial infections. It works by inhibiting bacterial cell wall synthesis; leading to bacterial cell death, in a result maintains high stability against β-lactamase-producing bacteria, including extended-spectrum β-lactamases (ESBL).
This injectable formulation is ideal for use in critical care settings. It offers rapid and reliable results in life-threatening infections.

Recommended by specialists:
✅Dermatologist: To treat skin and soft tissue infections.
✅Pulmonologist: To manage severe respiratory tract infections (e.g., pneumonia, ventilator-associated pneumonia).
✅Urologist: To prevent and treat complicated urinary tract infections.

Key benefits of Meropenem 125 mg Injection IP – MORPEX 125:
✅Broad-spectrum antibiotic: It is effective against a wide range of Gram-positive, Gram-negative, and anaerobic bacteria, making it ideal for poly-microbial infections.
✅Bactericidal action: Rapid and potent bactericidal activity by inhibiting bacterial cell wall synthesis.
✅Better Safety Profile: Well-tolerated with minimal adverse effects, suitable for critically ill patients.
✅Resistant to β-Lactamases: Stable against most β-lactamase enzymes, ensuring efficacy in resistant infections.

Indications-
✅Severe respiratory tract infections (e.g., pneumonia, including ventilator-associated pneumonia)
✅Complicated intra-abdominal infections
✅Complicated urinary tract infections
✅Bacterial meningitis
✅Skin and soft tissue infections
✅Sepsis and septic shock
✅Infections caused by multidrug-resistant organisms